vs
AC Immune SA(ACIU)与爱齐科技(ALGN)财务数据对比。点击上方公司名可切换其他公司
爱齐科技的季度营收约是AC Immune SA的729.2倍($1.0B vs $1.4M)。爱齐科技净利率更高(13.0% vs -1622.4%,领先1635.4%)。AC Immune SA同比增速更快(90.1% vs 5.3%)
AC Immune SA是一家临床阶段生物制药企业,专注于开发阿尔茨海默病、帕金森病及罕见tau蛋白病等神经退行性疾病的创新疗法与诊断方案,与全球领先药企展开合作,致力于满足神经疾病领域未被满足的临床需求。
爱齐科技是一家全球知名医疗设备企业,主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务,客户覆盖正畸医师、全科牙医,面向修复、美容牙科领域,业务分为透明矫治器、扫描仪及服务两大板块,可满足青少年等不同群体的正畸需求
ACIU vs ALGN — 直观对比
营收规模更大
ALGN
是对方的729.2倍
$1.4M
营收增速更快
ACIU
高出84.8%
5.3%
净利率更高
ALGN
高出1635.4%
-1622.4%
损益表 — Q2 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $1.4M | $1.0B |
| 净利润 | $-23.3M | $135.8M |
| 毛利率 | — | 65.3% |
| 营业利润率 | -1484.5% | 14.8% |
| 净利率 | -1622.4% | 13.0% |
| 营收同比 | 90.1% | 5.3% |
| 净利润同比 | 6.9% | 30.8% |
| 每股收益(稀释后) | — | $1.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACIU
ALGN
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $995.7M | ||
| Q2 25 | $1.4M | $1.0B | ||
| Q1 25 | — | $979.3M | ||
| Q4 24 | — | $995.2M | ||
| Q3 24 | — | $977.9M | ||
| Q2 24 | $755.7K | $1.0B | ||
| Q1 24 | — | $997.4M |
净利润
ACIU
ALGN
| Q4 25 | — | $135.8M | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | $-23.3M | $124.6M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $103.8M | ||
| Q3 24 | — | $116.0M | ||
| Q2 24 | $-25.0M | $96.6M | ||
| Q1 24 | — | $105.0M |
毛利率
ACIU
ALGN
| Q4 25 | — | 65.3% | ||
| Q3 25 | — | 64.2% | ||
| Q2 25 | — | 69.9% | ||
| Q1 25 | — | 69.5% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 69.7% | ||
| Q2 24 | — | 70.3% | ||
| Q1 24 | — | 70.0% |
营业利润率
ACIU
ALGN
| Q4 25 | — | 14.8% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | -1484.5% | 16.1% | ||
| Q1 25 | — | 13.4% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | -3051.1% | 14.3% | ||
| Q1 24 | — | 15.5% |
净利率
ACIU
ALGN
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | -1622.4% | 12.3% | ||
| Q1 25 | — | 9.5% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | -3313.0% | 9.4% | ||
| Q1 24 | — | 10.5% |
每股收益(稀释后)
ACIU
ALGN
| Q4 25 | — | $1.88 | ||
| Q3 25 | — | $0.78 | ||
| Q2 25 | — | $1.72 | ||
| Q1 25 | — | $1.27 | ||
| Q4 24 | — | $1.40 | ||
| Q3 24 | — | $1.55 | ||
| Q2 24 | — | $1.28 | ||
| Q1 24 | — | $1.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $28.3M | $1.1B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $82.2M | $4.0B |
| 总资产 | $209.2M | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ACIU
ALGN
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $28.3M | $901.2M | ||
| Q1 25 | — | $873.0M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $56.7M | $761.4M | ||
| Q1 24 | — | $865.8M |
股东权益
ACIU
ALGN
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | $82.2M | $3.9B | ||
| Q1 25 | — | $3.8B | ||
| Q4 24 | — | $3.9B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | $135.8M | $3.8B | ||
| Q1 24 | — | $3.8B |
总资产
ACIU
ALGN
| Q4 25 | — | $6.2B | ||
| Q3 25 | — | $6.2B | ||
| Q2 25 | $209.2M | $6.2B | ||
| Q1 25 | — | $6.1B | ||
| Q4 24 | — | $6.2B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | $261.3M | $6.2B | ||
| Q1 24 | — | $6.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $223.2M |
| 自由现金流经营现金流 - 资本支出 | — | $187.3M |
| 自由现金流率自由现金流/营收 | — | 17.9% |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | — | 1.64× |
| 过去12个月自由现金流最近4个季度 | — | $490.8M |
8季度趋势,按日历期对齐
经营现金流
ACIU
ALGN
| Q4 25 | — | $223.2M | ||
| Q3 25 | — | $188.7M | ||
| Q2 25 | — | $128.7M | ||
| Q1 25 | — | $52.7M | ||
| Q4 24 | — | $286.1M | ||
| Q3 24 | — | $263.7M | ||
| Q2 24 | — | $159.8M | ||
| Q1 24 | — | $28.7M |
自由现金流
ACIU
ALGN
| Q4 25 | — | $187.3M | ||
| Q3 25 | — | $169.0M | ||
| Q2 25 | — | $107.2M | ||
| Q1 25 | — | $27.4M | ||
| Q4 24 | — | $263.1M | ||
| Q3 24 | — | $233.9M | ||
| Q2 24 | — | $106.4M | ||
| Q1 24 | — | $19.3M |
自由现金流率
ACIU
ALGN
| Q4 25 | — | 17.9% | ||
| Q3 25 | — | 17.0% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | 1.9% |
资本支出强度
ACIU
ALGN
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | 0.9% |
现金转化率
ACIU
ALGN
| Q4 25 | — | 1.64× | ||
| Q3 25 | — | 3.33× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.27× | ||
| Q2 24 | — | 1.66× | ||
| Q1 24 | — | 0.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图